Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

ALLR3: An International Collaborative Trial for Relapsed and Refractory Acute Lymphoblastic Leukaemia (ALL)

NCT00967057 is registered in ClinicalTrials.gov with Children's Cancer and Leukaemia Group as lead sponsor.

NCT NCT00967057
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00967057 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
ALLR3: An International Collaborative Trial for Relapsed and Refractory Acute Lymphoblastic Leukaemia (ALL)
Lead sponsor
Children's Cancer and Leukaemia Group
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2002
Completion date
December 31, 2011
Enrollment
470 (estimated)
Sites
6

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia